deltatrials

Breast Cancer Trials in los angeles, united states

Conditions / Breast Cancer / los angeles, united states

305 total trials for this combination

Showing top 10 of 305 trials

Trials

NCT ID Title Status Phase
NCT01674140 S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions COMPLETED
NCT01358877 A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer COMPLETED PHASE3
NCT03155997 Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT05879926 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 RECRUITING PHASE3
NCT00625898 BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab TERMINATED PHASE3
NCT02032823 Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT00382070 Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT06492616 A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence RECRUITING PHASE3
NCT00053898 Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy COMPLETED PHASE3

Related Pages